Literature DB >> 19605741

How to dose infliximab in rheumatoid arthritis: new data on a serious issue.

Ronald F van Vollenhoven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19605741     DOI： 10.1136/ard.2009.111682

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  [Effect of increasing the infliximab dose in rheumatoid arthritis].

Authors:  M Schmalzing
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

Review 2.  Treatment of rheumatoid arthritis: state of the art 2009.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

Review 3.  Unresolved issues in biologic therapy for rheumatoid arthritis.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

4.  Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?

Authors:  Di Liu; Na Yuan; Guimei Yu; Ge Song; Yan Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.

Authors:  Jose Ramon Maneiro; Eva Perez-Pampin; Eva Salgado; Loreto Carmona; Juan J Gomez-Reino
Journal:  Rheumatol Int       Date:  2013-07-28       Impact factor: 2.631

6.  Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.

Authors:  Tsutomu Takeuchi; Nobuyuki Miyasaka; Yoshihiko Tatsuki; Toshiro Yano; Toru Yoshinari; Tohru Abe; Takao Koike
Journal:  Ann Rheum Dis       Date:  2011-04-08       Impact factor: 19.103

7.  Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

Authors:  Lise M Verhoef; Bart Jf van den Bemt; Aatke van der Maas; Johanna E Vriezekolk; Marlies E Hulscher; Frank Hj van den Hoogen; Wilco Ch Jacobs; Noortje van Herwaarden; Alfons A den Broeder
Journal:  Cochrane Database Syst Rev       Date:  2019-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.